Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

PTRA Stock Alert: Nasdaq Suspends Proterra Trading

By Chris MacDonald, InvestorPlace Contributor

One of the more notable news stories today involves the halting of PTRA stock, as Proterra declares bankruptcy.

3 Millionaire-Maker AI Stocks to Hold Through Thick and Thin

By Chris MacDonald, InvestorPlace Contributor

Here are three millionaire-maker AI stocks that have already minted plenty of millionaires, with more to come.

Do NOT Put this Cannabis Stock In Your Pipe and Smoke It

By Chris MacDonald, InvestorPlace Contributor

Here's why cannabis giant Tilray may simply be too risky at this point in the cycle for investors of all stripes to consider.

Dividend Hunters: 3 Stock Gems to Boost Your Passive Income

By Chris MacDonald, InvestorPlace Contributor

These three stock gems are among the best bets long-term investors can make in the defensive areas of the market: dividend stocks.

MRNA Stock Alert: Why Is Moderna Up 7% Today?

By Chris MacDonald, InvestorPlace Contributor

Investors in Moderna (MRNA) stock have received a boost today from reports that a late summer Covid wave could be on the horizon.

Load More